Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Horizon Pharma PLC (NASDAQ:HZNP)

36.85
Delayed Data
As of Jul 31
 +0.54 / +1.49%
Today’s Change
8.07
Today|||52-Week Range
39.49
+185.88%
Year-to-Date

Today’s Trading

Previous close36.31
Today’s open36.42
Day’s range36.12 - 37.79
Volume2,248,772
Average volume (3 months)3,305,055
Market cap$5.9B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-34.62%
Earnings growth (this year)+41.54%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+301.20%
P/E ratioNM
Price/Sales3.64
Price/Book8.80

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...+0.75+0.54%
SGENSeattle Genetics Inc+0.53+1.12%
IDXXIDEXX Laboratories I...+1.39+1.95%
AKRXAkorn Inc-0.22-0.47%
Data as of 4:02pm ET, 07/31/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)$0.33
Annual revenue (last year)$297.0M
Annual profit (last year)-$263.6M
Net profit margin-88.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Timothy P. Walbert
SVP-Business Operations &
Government Affairs
Robert W. Metz
Corporate headquarters
Dublin, Dublin

Forecasts